Cynata Therapeutics (ASX:CYP) receives U.K. approval for CLI trial
- Cynata Therapeutics (CYP) has received approval from the U.K. Medicines and Healthcare products Regulatory Agency to begin the phase 2 trial of CYP-002
- This product will be used in patients with reduced blood flow in their limbs
- The company anticipates conducting the clinical trial at multiple centres in the U.K. and Australia
Cynata Therapeutics (ASX:CYP) receives U.K. approval for CLI...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
-0.005(2.50%) |
Mkt cap ! $35.23M | |||
| Open | High | Low | Value | Volume |
| 19.5¢ | 19.5¢ | 18.5¢ | $14.31K | 75.89K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 30232 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 10000 | 1 |
View Market Depth
| Last trade - 14.43pm 09/09/2024 (20 minute delay) ? |
| CYP (ASX) Chart |